Teladoc Health (NYSE:TDOC) Price Target Lowered to $10.00 at Deutsche Bank Aktiengesellschaft

Teladoc Health (NYSE:TDOC) had its price objective reduced by Deutsche Bank Aktiengesellschaft from $15.00 to $10.00 in a research note issued to investors on Friday morning, Benzinga reports. They currently have a hold rating on the health services provider’s stock.

A number of other equities analysts also recently commented on TDOC. JPMorgan Chase & Co. decreased their price target on Teladoc Health from $19.00 to $16.00 and set a neutral rating for the company in a research note on Tuesday, May 21st. Bank of America decreased their price target on Teladoc Health from $16.50 to $13.50 and set a neutral rating for the company in a research note on Tuesday, May 14th. DA Davidson decreased their price target on Teladoc Health from $12.00 to $8.00 and set a neutral rating for the company in a research note on Thursday, August 1st. Wells Fargo & Company decreased their price target on Teladoc Health from $17.00 to $15.00 and set an equal weight rating for the company in a research note on Monday, April 29th. Finally, Royal Bank of Canada decreased their price target on Teladoc Health from $25.00 to $18.00 and set an outperform rating for the company in a research note on Friday, April 26th. Fourteen analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of Hold and a consensus target price of $13.56.

Teladoc Health Stock Down 1.7 %

NYSE:TDOC traded down $0.13 during mid-day trading on Friday, reaching $7.47. The stock had a trading volume of 3,513,032 shares, compared to its average volume of 5,470,642. The company has a market capitalization of $1.27 billion, a price-to-earnings ratio of -5.39 and a beta of 0.93. Teladoc Health has a 1-year low of $7.31 and a 1-year high of $26.00. The stock’s 50 day simple moving average is $9.81 and its two-hundred day simple moving average is $13.52. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74.

Insider Transactions at Teladoc Health

In other news, CEO Laizer Kornwasser sold 10,879 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $88,555.06. Following the completion of the transaction, the chief executive officer now directly owns 99,929 shares in the company, valued at $813,422.06. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Karen L. Daniel sold 9,834 shares of the business’s stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total transaction of $117,024.60. Following the sale, the director now owns 36,995 shares of the company’s stock, valued at $440,240.50. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Laizer Kornwasser sold 10,879 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $88,555.06. Following the sale, the chief executive officer now directly owns 99,929 shares in the company, valued at approximately $813,422.06. The disclosure for this sale can be found here. Over the last three months, insiders sold 36,177 shares of company stock worth $347,447. Company insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Arizona State Retirement System raised its holdings in Teladoc Health by 4.2% during the second quarter. Arizona State Retirement System now owns 47,400 shares of the health services provider’s stock worth $464,000 after purchasing an additional 1,901 shares in the last quarter. Foundations Investment Advisors LLC increased its holdings in shares of Teladoc Health by 101.2% in the second quarter. Foundations Investment Advisors LLC now owns 58,934 shares of the health services provider’s stock valued at $576,000 after buying an additional 29,646 shares in the last quarter. Rhumbline Advisers increased its holdings in shares of Teladoc Health by 62.9% in the second quarter. Rhumbline Advisers now owns 276,535 shares of the health services provider’s stock valued at $2,704,000 after buying an additional 106,770 shares in the last quarter. AM Squared Ltd bought a new position in shares of Teladoc Health in the second quarter valued at $100,000. Finally, nVerses Capital LLC increased its holdings in shares of Teladoc Health by 1,600.0% in the second quarter. nVerses Capital LLC now owns 11,900 shares of the health services provider’s stock valued at $116,000 after buying an additional 11,200 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.